159 related articles for article (PubMed ID: 38195952)
21. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
22. Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort.
Jie Y; Peng W; Li YY
Aging (Albany NY); 2021 Feb; 13(4):5698-5717. PubMed ID: 33591944
[TBL] [Abstract][Full Text] [Related]
23. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling.
Du Y; Xin Z; Liu T; Xu P; Mao F; Yao J
J Cancer Res Clin Oncol; 2021 May; 147(5):1557-1564. PubMed ID: 33387040
[TBL] [Abstract][Full Text] [Related]
24. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
[TBL] [Abstract][Full Text] [Related]
25. Developing and validating a survival prediction model based on blood exosomal ceRNA network in patients with PAAD.
Wang S; Xu L; Zhu K; Zhu H; Zhang D; Wang C; Wang Q
BMC Med Genomics; 2022 Dec; 15(1):260. PubMed ID: 36522691
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
Li Y; Su Z; Wei B; Qin M; Liang Z
Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
[TBL] [Abstract][Full Text] [Related]
27. Expression, prognostic value and mechanism of SP100 family in pancreatic adenocarcinoma.
Duan Y; Du Y; Mu Y; Gu Z; Wang C
Aging (Albany NY); 2023 Jun; 15(12):5569-5591. PubMed ID: 37354211
[TBL] [Abstract][Full Text] [Related]
28. [Over-expression of NUDT21 inhibits the proliferation of HCT-116 colon cancer cells via blocking P53/CDK2/Rb pathway].
Luo Z; Dou L; Wang L; Liu R; Luo G; Lin M; Deng Z; Shen Y; Fu Z; Peng S; Zhang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Jun; 38(6):507-512. PubMed ID: 35732608
[TBL] [Abstract][Full Text] [Related]
29. Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma.
Gan XY; Li JD; Chen G; He RQ; Luo JY; Zeng JJ; Yang ZX; Yao YX; Zhu JJ; Li JJ; Wei DM
Dig Dis Sci; 2023 May; 68(5):1894-1912. PubMed ID: 36459296
[TBL] [Abstract][Full Text] [Related]
30. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
[TBL] [Abstract][Full Text] [Related]
31. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract][Full Text] [Related]
32. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
Xu Q; Zheng J; Su Z; Chen B; Gu S
BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
[TBL] [Abstract][Full Text] [Related]
33. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
Du W; Lei C; Wang Y; Ding Y; Tian P
Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
[TBL] [Abstract][Full Text] [Related]
34. The role of NUDT21 in microRNA-binging sites of EZH2 gene increases the of risk preeclampsia.
Lang X; Zhao W; Huang D; Liu W; Shen H; Xu L; Xu S; Huang Y; Cheng W
J Cell Mol Med; 2019 May; 23(5):3202-3213. PubMed ID: 30883033
[TBL] [Abstract][Full Text] [Related]
35. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of NF-κB activating protein promotes pancreatic cancer growth and metastasis through mTOR signaling pathway.
Xu X; Hou D; Wang Y; Zhang J; Hei Y; Wang B; Tian S; Zhang Y; Wang F
Mol Biol Rep; 2023 Sep; 50(9):7501-7513. PubMed ID: 37486443
[TBL] [Abstract][Full Text] [Related]
37. CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma.
Liu K; Li L; Han G
Front Endocrinol (Lausanne); 2023; 14():1226547. PubMed ID: 38333724
[TBL] [Abstract][Full Text] [Related]
38. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
39. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
Huang Y; Gong P; Su L; Zhang M
Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway.
Xu X; Yu Y; Zong K; Lv P; Gu Y
J Exp Clin Cancer Res; 2019 Dec; 38(1):497. PubMed ID: 31852504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
